Information about IAS 2013

Article

News and updates about the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013).

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013)

June 30 — July 3, 2013

Kuala Lumpur, Malaysia

Visit the main IAS 2013 website to access the latest news and updates about the conference.

The complete schedule for IAS 2013 is available online, along with a downloadable IAS 2013 Programme-at-a-Glance (PAG).

A PAG app is available for download for the iPhone/iPad and for Android devices.

Attendees should also download the IAS 2013 general information guide, which offers “useful and practical information about the conference.”

Additional information about the IAS 2013 conference agenda is also available online:

  • The daily plenary sessions feature “some of the world’s most distinguished HIV scientists, policy specialists and community leaders. Plenary sessions will bring together all conference delegates at the first session of every morning.”
  • Abstract-driven sessions will offer “the highest caliber of state-of-the-art knowledge and peer-reviewed research. Abstract driven sessions are either specific to one of the four tracks (A-D), or involve abstract from different tracks but focusing on one theme.”
  • Professional development workshops “will cover all tracks and include several cross-cutting issues and themes. Delegates will be able to participate in targeted workshops that will promote and enhance opportunities for knowledge transfer, skills development and collaborative learning.”

Information about abstracts at IAS 2013 is available here.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.